跳至主要内容
临床试验/JPRN-UMIN000026107
JPRN-UMIN000026107招募中未知

Investigation of the usefulness of ACCURO for epidural anesthesia - Investigation of the usefulness of ACCURO for epidural anesthesia

Department of Anesthesiology Sapporo Medical University0 个研究点目标入组 100 人开始时间: 2017年2月13日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • coagulopathy

研究者

发起方
Department of Anesthesiology Sapporo Medical University

相似试验

招募中
不适用
Comparative Investigating the effect of the Auricolotherapy and mindfulness-based stress reduction counseling on the nausea and vomiting of pregnancy in pregnant wome
IRCT20210728052005N1Kerman University of Medical Sciences159
进行中(未招募)
不适用
A study of the Safety and Efficacy of Anecortave Acetate for Treatment of Steroid Induced IOP Elevation - Anecortave Acetate for treatment of steroid induced IOP elevatiopatient with elevated intraocular pressure following steroid treatment (any route).MedDRA version: 9.1Level: LLTClassification code 10030043Term: Ocular hypertension
EUCTR2006-003356-38-ITAlcon Research Limited60
进行中(未招募)
不适用
A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of SteroidInduced IOP Elevation - Anecortave Acetate for Treatment of Steroid Induced IOP ElevatioElevated intraocular pressure (IOP) following intravitreal injection with a corticosteroid (steroid induced IOP elavation).
EUCTR2006-003356-38-BEAlcon Research Limited60
进行中(未招募)
不适用
A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of SteroidInduced IOP Elevation - Anecortave Acetate for Treatment of Steroid Induced IOP ElevatioElevated intraocular pressure (IOP) following treatment with a corticosteroid (steroid induced IOP elavation).
EUCTR2006-003356-38-HUAlcon Research Limited60
进行中(未招募)
不适用
A Study of the Safety and Efficacy of Anecortave Acetate for Treatment of SteroidInduced IOP Elevation - Anecortave Acetate for Treatment of Steroid Induced IOP Elevatio
EUCTR2006-003356-38-NLAlcon Research Limited60